Teva Pharmaceutical's total assets for Q3 2025 were $39.86B, a decrease of -0.69% from the previous quarter. TEVA total liabilities were $32.60B for the fiscal quarter, a -2.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.